Literature DB >> 18618

Severe combined immunodeficiency disease. Characterization of the disease and results of transplantation.

M M Bortin, A A Rimm.   

Abstract

Pretransplant and posttransplant data for 69 patients with severe combined immunodeficiency disease are presented. Both B and T lymphocyte functions were absent in approximately 80% of the children and markedly depressed in the remainder. Transplantation of marrow from HLA genotypically identical donors provided the highest six-month survival rate (63%); six-month survival rates for patients who received fetal tissue transplants (43%) or marrow from mixed leukocyte culture (MLC) negative donors (38%) were significantly higher (P less than .05) than for patients treated with marrow from MLC positive donors (5%). Additional factors appeared to influence survival and the severity of graft-vs-host (GVH) disease. Patients more than 6 months of age had more intense GVH disease than younger patients. Survival rates were lower and GVH disease more intense when boys received transplants from girl donors than the reverse.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18618

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  38 in total

Review 1.  Transplantation immunology: solid organ and bone marrow.

Authors:  Javier Chinen; Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

2.  Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.

Authors:  M L Markert; J J Hutton; D A Wiginton; J C States; R E Kaufman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 3.  Bone marrow transplantation. Part I--Allogeneic.

Authors:  N J Chao; K G Blume
Journal:  West J Med       Date:  1989-12

4.  Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.

Authors:  W Friedrich; S F Goldmann; W Ebell; R Blütters-Sawatzki; G Gaedicke; A Raghavachar; H H Peter; B Belohradsky; W Kreth; B Kubanek
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

5.  Alternatives to donor matching for control of graft-versus-host disease.

Authors:  H M Vriesendorp; W M Klapwijk; T P Visser; C Zurcher; D W van Bekkum
Journal:  Immunogenetics       Date:  1982-01       Impact factor: 2.846

6.  Early diagnosis of severe combined immunodeficiency syndrome.

Authors:  R A Hague; S Rassam; G Morgan; A J Cant
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

7.  Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man.

Authors:  A Janin-Mercier; A Devergie; D Van Cauwenberge; J H Saurat; M Bourges; C M Lapiere; E Gluckman
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

8.  Long-term immunological reconstitution by peripheral blood leucocytes in severe combined immune deficiency disease: implications for the role of mature lymphocytes in histocompatible bone marrow transplantation.

Authors:  S H Polmar; B Z Schacter; R U Sorensen
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  Pulmonary disease following allogeneic bone marrow transplantation.

Authors:  M Murray; D S O'Briain; J Prichard; S R McCann
Journal:  Ir J Med Sci       Date:  1989-02       Impact factor: 1.568

10.  Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.

Authors:  K C Rich; C M Richman; E Mejias; P Daddona
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.